Arcutis Biotherapeutics, Inc. (ARQT) stock
ARQTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30403% above fair value
$27.33+0.18 (+0.66%)
Close on Nov 17, 2026Market cap $3.44BP/E 124.2Yield –
Arcutis Biotherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Arcutis Biotherapeutics's market cap was $3.56B on Nov 11, 2026, against $3.69B a year earlier. Over the last 5 years it ranged from $113.82M to $4.03B, with a median of $1.09B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.56B | +2.0% |
| 2025 | Dec 31, 2025 | $3.49B | +114.3% |
| 2024 | Dec 31, 2024 | $1.63B | +715.7% |
| 2023 | Dec 29, 2023 | $199.80M | -77.8% |
| 2022 | Dec 30, 2022 | $901.45M | -13.3% |
| 2021 | Dec 31, 2021 | $1.04B | -2.2% |
| 2020 | Dec 31, 2020 | $1.06B | – |
See a number that looks wrong?